The antimicrobial activities of BMY-28142, cefbuperazone (BMY-25182; formerly T-1982), and cefpiramide (WY-44635; formerly SM-1652) were compared with those of cefmenoxime, cefoperazone, cefotaxime, ceftizoxime, and moxalactam. BMY-28142 was the most active cephalosporin against the majority of aerobic and facultatively anaerobic microorganisms studied. Its spectrum of activity was very similar to that of cefotaxime. However, BMY-28142, cefbuperazone, cefmenoxime, cefotaxime, ceftizoxime, and moxalactam were equivalent in activity and rate of killing against members of the family Enterobacteriaceae. Cefpiramide was considerably less active than the other cephalosporins against the Enterobacteriaceae.
There has been remarkable progress in the development of new P-lactam antibiotics in the past few years (1, 5). These antimicrobial agents possess increased resistance to hydrolysis by bacteria-mediated P-lactamases (10, 14) , excellent activity against aerobic and facultative anaerobic gramnegative bacteria (10, 11, 16) , and favorable pharmacokinetic properties (4, 7) . Many of these compounds have been the subjects of clinical and laboratory trials to evaluate their efficacy (5, (16) (17) (18) (19) . Several 576, 1983 ). Information on their in vitro spectra of activity, however, is limited (3, 8, 9, 20, 21) . In this report we compared the in vitro antibacterial activity of these cephalosporins with those of cefmenoxime, cefoperazone, cefotaxime, ceftizoxime, and moxalactam against fresh nosocomial isolates. In addition, the bactericidal activities of these antimicrobial agents were determined by a time-kill assay.
The cephalosporins compared in this study were chosen to represent those used clinically and those in the final stages of development. The 
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These results suggest that most of the cephalosporins, except cefpiramide and cefoperazone, have equivalent antimicrobial activities against the Enterobacteriaceae. Therefore, the cephalosporins were compared for their rate of killing against Enterobacter sp., Escherichia coli, K. pneumoniae and Serratia marcescens (Fig. 1) . At a MIC of 0,25 ,ug/ml, equivalent killing of bacteria (2 logs against the majority of the microorganisms tested. Its spectrum of activity was very similar to that of cefotaxime. Cefotaxime failed to inhibit the growth of only Pseudomonas aeruginosa (MIC90 -128 ,ug/ml) and Staphylococcus epidermidis (MIC90 2 16 ,ug/ml). Surprisingly, no significant differences in activities were detected among BMY-28142, cefbuperazone, cefmenoxime, cefotaxime, ceftizoxime, and moxalactam against the Enterobacteriaceae. Time-kill curves (Fig. 1) 
